Menus Subscribe Search

Follow us


The Chemical Contrails of the Placebo

• November 30, 2009 • 5:00 AM

Studies are finding that the pain relief induced by placebos may come from releasing the body’s own chemical pain relievers.

A team of researchers smears a cream said to contain a powerful anesthetic on the skin of your forearm. Then, in their mad-scientist way, they apply an electric heating pad that can be dialed up to painfully hot levels.

Imagine being pleasantly surprised to find that the cream works — the heat seems quite bearable. The researchers even run a brain scan to document just how well this cream works.

But picture your dismay at learning that the cream was actually inert and contained no anesthetic. Nada.

Guileless lab rat that you are, you have been punked. By a placebo.

Scenes like this are playing out in U.S. and European laboratories as neuroscientists try to figure out how our brains can be tricked by sham treatments into producing potent pain-blocking effects that rival (and may sometimes enhance) the effects of real drugs.

The details of the emerging picture are still being sketched in, but it seems that our expectations — whether shaped through conditioning or a simple verbal instruction — can trigger our native pain-control networks, some of which extend from higher cognitive regions deep into the brain stem and spinal cord.

In recent papers published in Science and Neuron, a team of scientists led by Falk Eippert and Ulrike Bingel at University Medical Center Hamburg-Eppendorf in Germany explored how placebos activate the brain’s “descending pain control system,” which involves structures in the brain stem. It’s a complex process that relies on opioids — naturally produced substances that chemically resemble opium and block the transmission of pain signals.

The scientists induced the placebo effect in their 48 test subjects by falsely telling them they were applying a cream containing lidocaine, a topical anesthetic. But some subjects also received naloxone, a drug that blocks the effects of opioids (the rest got an inert injection of saline solution).

Next, the scientists studied their subjects’ brains with a functional magnetic resonance imaging scanner and asked them to subjectively rate the pain intensity.

The subjects who received naloxone (which blocked opioid activity in the dorsolateral prefrontal cortex and midbrain structures like the rostral anterior cingulate cortex, amygdala, hypothalamus, the periaqueductal gray and the rostral ventromedial medulla) saw markedly lower pain relief than those who had received saline, the team reported.

“Until now it was believed that placebo was just a psychological phenomenon that has no neurobiological basis, but that’s really not the case,” Eippert said. He noted that naloxone did not completely erase the pain-relief effect, suggesting that placebo treatment may also engage other less-studied brain networks.

The placebo effect is probably at work even when proven opiates are administered for pain relief, Eippert said. Experiments have shown that patients experience some pain relief when they are given opiates without their knowledge, which is no surprise. “However, when you give this drug and tell the patient, the pain relief is going to be much, much stronger,” he said. “The interesting thing is if you give naloxone at the same time, then this additional effect of telling the patient is completely canceled. There’s a placebo component in treatment as well.”

Tor Wager, an associate professor of psychology at Columbia University, has shown that placebos are associated with increased activity in the brain’s frontal cortex, which sends projections deep into the brain stem, where physiological responses to emotional events are regulated.

Wager hailed Eippert’s study for conclusively showing the role of opioids in placebo pain control and for showing how much of the effect happens in the spinal cord.

“These are new insights,” Wager said. “It’s surprising that you could get a signal in a spinal cord … much less influence it with a placebo treatment.”

The placebo effect has long vexed drug companies conducting expensive drug trials, Wager said. Scientists have had a hard time accepting the validity of placebo effects “because we think of psychological things as not real, and we think of drugs as being physical,” he said. “The truth is, thoughts and feelings — particularly strong emotional states — are physiological and neurochemical events in your brain.”

Wager is curious about what physiological changes occur in the brain when an expectation is created. Expectations involve making a prediction about the future that draws on the memory of past experience and is related to the self, he said.

A key area of interest is the ventral medial prefrontal cortex, the region that is activated when people make judgments about how things relate to them, as opposed to others.

“This is the only area of the cortex — in monkeys and rats, at least — that sends projections all the way back down to the brain stem nuclei that control the spinal cord,” Wager said. “They control the autonomic nervous system. It’s a major source of projections to essentially the brain’s stress system in the hypothalamus and the brain’s pain control system. It’s the right area to be seeing increased opioid release with placebo.”

Meanwhile, Swiss neuroscientist Peter Krummenacher and his colleagues report in a forthcoming study in the journal Pain that the use of repetitive transcranial magnetic stimulation (or rTMS) to temporarily disable the left and right dorsolateral prefrontal cortex “completely blocked” placebo-based pain relief.

They subjected their 40 male subjects to rTMS — which induces an electric current in the brain — on both sides of the head and achieved identical results. The researchers noted that the dorsolateral prefrontal cortex plays a major role in higher cognition, working memory and general attention. If the placebo response disappears when that region is temporarily disabled, they wrote, it might be “a consequence of a transiently disrupted cognitive representation of pain analgesia and the result of redirected attention away from pain.”

All this new research could help pharmaceutical companies better understand the role that placebos play in the efficacy of their treatments — an urgent need, Columbia’s Tor Wager said, since clinical trials that can cost as much as $100 million often founder on placebo effects.

“What these studies do is help to understand what the neurobiological principles are,” Wager said. “It can lead to ideas and treatments that we hadn’t thought of because we understand the neurobiological principles.”

Sign up for our free e-newsletter.

Are you on Facebook? Become our fan.

Follow us on Twitter.

Add our news to your site.

Michael Haederle
Michael Haederle lives in New Mexico. He has written for the Los Angeles Times, People Magazine, Tricycle: The Buddhist Review and many other publications. He has also taught at Syracuse University's S.I. Newhouse School of Public Communications and is a Zen lay monk.

More From Michael Haederle

A weekly roundup of the best of Pacific Standard and PSmag.com, delivered straight to your inbox.

Recent Posts

October 24 • 4:00 PM

We Need to Normalize Drug Use in Our Society

After the disastrous misconceptions of the 20th century, we’re returning to the idea that drugs are an ordinary part of life experience and no more cause addiction than do other behaviors. This is rational and welcome.


October 24 • 2:00 PM

A Letter to the Next Attorney General: Fix Presidential Pardons

More than two years ago, a series showed that white applicants were far more likely to receive clemency than comparable applicants who were black. Since then, the government has spent hundreds of thousands of dollars on a study, but the pardons system remains unchanged.


October 24 • 12:00 PM

What Makes You So Smart, Middle School Math Teacher?

Noah Davis talks to Vern Williams about what makes middle school—yes, middle school—so great.


October 24 • 10:00 AM

Why DNA Is One of Humanity’s Greatest Inventions

How we’ve co-opted our genetic material to change our world.


October 24 • 8:00 AM

What Do Clowns Think of Clowns?

Three major players weigh in on the current state of the clown.


October 24 • 7:13 AM

There Is No Surge in Illegal Immigration

The overall rate of illegal immigration has actually decreased significantly in the last 10 years. The time is ripe for immigration reform.


October 24 • 6:15 AM

Politicians Really Aren’t Better Decision Makers

Politicians took part in a classic choice experiment but failed to do better than the rest of us.


October 24 • 5:00 AM

Why We Gossip: It’s Really All About Ourselves

New research from the Netherlands finds stories we hear about others help us determine how we’re doing.


October 24 • 2:00 AM

Congratulations, Your City Is Dying!

Don’t take population numbers at face value.


October 23 • 4:00 PM

Of Course Marijuana Addiction Exists

The polarized legalization debate leads to exaggerated claims and denials about pot’s potential harms. The truth lies somewhere in between.


October 23 • 2:00 PM

American Companies Are Getting Way Too Cozy With the National Security Agency

Newly released documents describe “contractual relationships” between the NSA and U.S. companies, as well as undercover operatives.


October 23 • 12:00 PM

The Man Who’s Quantifying New York City

Noah Davis talks to the proprietor of I Quant NY. His methodology: a little something called “addition.”


October 23 • 11:02 AM

Earliest High-Altitude Settlements Found in Peru

Discovery suggests humans adapted to high altitude faster than previously thought.


October 23 • 10:00 AM

The Psychology of Bribery and Corruption

An FBI agent offered up confidential information about a political operative’s enemy in exchange for cash—and they both got caught. What were they thinking?


October 23 • 8:00 AM

Ebola News Gives Me a Guilty Thrill. Am I Crazy?

What it means to feel a little excited about the prospect of a horrific event.


October 23 • 7:04 AM

Why Don’t Men Read Romance Novels?

A lot of men just don’t read fiction, and if they do, structural misogyny drives them away from the genre.


October 23 • 6:00 AM

Why Do Americans Pray?

It depends on how you ask.


October 23 • 4:00 AM

Musicians Are Better Multitaskers

New research from Canada finds trained musicians more efficiently switch from one mental task to another.


October 22 • 4:00 PM

The Last Thing the Women’s Movement Needs Is a Heroic Male Takeover

Is the United Nations’ #HeForShe campaign helping feminism?


October 22 • 2:00 PM

Turning Public Education Into Private Profits

Baker Mitchell is a politically connected North Carolina businessman who celebrates the power of the free market. Every year, millions of public education dollars flow through Mitchell’s chain of four non-profit charter schools to for-profit companies he controls.


October 22 • 12:00 PM

Will the End of a Tax Loophole Kill Off Irish Business and Force Google and Apple to Pay Up?

U.S. technology giants have constructed international offices in Dublin in order to take advantage of favorable tax policies that are now changing. But Ireland might have enough other draws to keep them there even when costs climb.


October 22 • 10:00 AM

Veterans in the Ivory Tower

Why there aren’t enough veterans at America’s top schools—and what some people are trying to do to change that.


October 22 • 8:00 AM

Our Language Prejudices Don’t Make No Sense

We should embrace the fact that there’s no single recipe for English. Making fun of people for replacing “ask” with “aks,” or for frequently using double negatives just makes you look like the unsophisticated one.


October 22 • 7:04 AM

My Politicians Are Better Looking Than Yours

A new study finds we judge the cover by the book—or at least the party.


October 22 • 6:00 AM

How We Form Our Routines

Whether it’s a morning cup of coffee or a glass of warm milk before bed, we all have our habitual processions. The way they become engrained, though, varies from person to person.


Follow us


Politicians Really Aren’t Better Decision Makers

Politicians took part in a classic choice experiment but failed to do better than the rest of us.

Earliest High-Altitude Settlements Found in Peru

Discovery suggests humans adapted to high altitude faster than previously thought.

My Politicians Are Better Looking Than Yours

A new study finds we judge the cover by the book—or at least the party.

That Cigarette Would Make a Great Water Filter

Clean out the ashtray, add some aluminum oxide, and you've (almost) got yourself a low-cost way to remove arsenic from drinking water.

Love and Hate in Israel and Palestine

Psychologists find that parties to a conflict think they're motivated by love while their enemies are motivated by hate.

The Big One

One company, Amazon, controls 67 percent of the e-book market in the United States—down from 90 percent five years ago. September/October 2014 new-big-one-5

Copyright © 2014 by Pacific Standard and The Miller-McCune Center for Research, Media, and Public Policy. All Rights Reserved.